Disruption of the expected positive correlation between breast tumor size and lymph node status inBRCA1-related breast carcinoma-Reference-Cited by-同舟云学术

Disruption of the expected positive correlation between breast tumor size and lymph node status inBRCA1-related breast carcinoma

Published:2003-09-08 Issue:8 Volume:98 Page:1569-1577
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Foulkes William D.,Metcalfe Kelly,Hanna Wedad,Lynch Henry T.,Ghadirian Parviz,Tung Nadine,Olopade Olofunmilayo,Weber Barbara,McLennan Jane,Olivotto Ivo A.,Sun Ping,Chappuis Pierre O.,Bégin Louis R.,Brunet Jean-Sébastien,Narod Steven A.

Funder

Canadian Genetic Diseases Network

Susan G. Komen Foundation

Fonds de la recherche en Santé du Québec

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cancer of the breast: size of neoplasm and prognosis;Fisher;Cancer,1969

2. Implications from SEER data on breast cancer management;Smart;Cancer,1978

3. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons;Nemoto;Cancer,1980

4. Factors affecting the incidence of lymph node metastases in small cancers of the breast;Reger;Am J Surg,1989

5. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases;Carter;Cancer,1989

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Classification and Respective Radiological Phenotypes of Breast Cancers;Hong Kong Journal of Radiology;2023-09-11

2. Triple negative breast cancer: anatomoclinical and molecular particularities;PAN AFR MED J;2022

3. Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study;Breast Cancer Research and Treatment;2022-05-04

4. Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses;Cancers;2022-02-16

5. The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease;Breast Cancer;2021-11-15